Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

339
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339
Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

281
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

322
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
322
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EDX Array Tomography: 3D Imaging With Chemical Sensitivity and Submicron Resolution Through Ultramicrotomy and SEM-EDX Mapping.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2026
Same author

Laying the Foundation for Digital Material Design of Porous Transport Electrodes for PEM Water Electrolysis With Multiscale Tomography.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Evolution of Bovine Herpesvirus-1 infection prevalence and infection dynamics in Irish dairy herds following an IBR hyperimmunisation vaccination protocol.

Irish veterinary journal·2025
Same author

Clinical Applications and Measurement Properties of the Digitized Archimedes Spiral Drawing Test: A Scoping Review.

Movement disorders clinical practice·2025
Same author

Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.

Journal of sleep research·2021
Same author

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.

Human psychopharmacology·2020
Same journal

Does Aging Affect Diet-Induced Thermogenesis? Revisiting the Evidence from Human Studies.

Current obesity reports·2026
Same journal

Lipid Metabolic Disorders: a Pivotal Driver in Type 2 Diabetes Mellitus Pathogenesis.

Current obesity reports·2026
Same journal

Adipose Tissue Plasticity and Adipogenesis: From Cellular Mechanisms to Therapeutic Targets in Obesity.

Current obesity reports·2026
Same journal

Beyond Single Anthropometric Measures: Integrating Waist Circumference and Body Mass Index to Stratify Obesity-Related Health Risk.

Current obesity reports·2026
Same journal

Correction: Distinct From the Adult Paradigm: Re-Evaluate the Pathophysiological and Therapeutic Framework in Children and Adolescent Hyperlipidaemia.

Current obesity reports·2026
Same journal

Distinct From the Adult Paradigm: Re-Evaluate the Pathophysiological and Therapeutic Framework in Children and Adolescent Hyperlipidaemia.

Current obesity reports·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

5.1K

Relationship Between Obesity and Driving.

Gary G Kay1, David McLaughlin2

  • 1Cognitive Research Corporation, 200 Central Avenue, Suite 1230, St. Petersburg, FL, 33701, USA. gkay@cogres.com.

Current Obesity Reports
|December 3, 2015
PubMed
Summary
This summary is machine-generated.

Obesity increases crash risk, especially for commercial truck drivers. Addressing obesity and related conditions like obstructive sleep apnea (OSA) can improve safety.

Keywords:
Body mass index (BMI)DrivingExcessive daytime sleepiness (EDS)ObesityObstructive sleep apnea (OSA)

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 29, 2026

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

5.1K
Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Area of Science:

  • Occupational health
  • Public health
  • Transportation safety

Background:

  • Obesity is a global epidemic and a known risk factor for various diseases.
  • Obesity is increasingly recognized as a significant factor contributing to increased crash risk and injury severity.
  • Commercial truck drivers face a high prevalence of obesity due to lifestyle factors.

Purpose of the Study:

  • To review the association between obesity and crash risk in commercial truck drivers.
  • To highlight the contributing factors to obesity in this population.
  • To emphasize the public safety benefits of screening for obesity-related conditions.

Main Methods:

  • Review of existing data and literature on obesity prevalence in truck drivers.
  • Analysis of the relationship between obesity, obstructive sleep apnea (OSA), and driving safety.
  • Discussion of contributing factors to obesity in the trucking industry.

Main Results:

  • Obesity is highly prevalent among commercial truck drivers.
  • Obesity is linked to an increased risk of vehicle crashes and serious injuries.
  • Obstructive sleep apnea (OSA), an obesity-related condition, significantly elevates crash risk.

Conclusions:

  • Obesity poses a substantial risk to public safety, particularly within the commercial trucking industry.
  • Screening truck drivers for obesity and related conditions like OSA is crucial for enhancing road safety.
  • Interventions targeting obesity and OSA in drivers can lead to improved driving performance and reduced crashes.